Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The promises of personalized medicine.

Literature DB >> 20563567

The promises of personalized medicine.

Ingolf Cascorbi.

Abstract

Mesh：

Substances：

Year: 2010 PMID： 20563567 DOI： 10.1007/s00228-010-0858-6

Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN： 0031-6970 Impact factor: 2.953

× No keyword cloud information.

31 in total

1. CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages.

Authors: J Kirchheiner; K Brøsen; M L Dahl; L F Gram; S Kasper; I Roots; F Sjöqvist; E Spina; J Brockmöller
Journal: Acta Psychiatr Scand Date: 2001-09 Impact factor: 6.392

2. High frequency of occurrence of CYP2D6 gene duplication/multiduplication indicating ultrarapid metabolism among suicide cases.

Authors: A L Zackrisson; B Lindblom; J Ahlner
Journal: Clin Pharmacol Ther Date: 2009-11-11 Impact factor: 6.875

Review 3. Pharmacogenomics and individualized drug therapy.

Authors: Michel Eichelbaum; Magnus Ingelman-Sundberg; William E Evans
Journal: Annu Rev Med Date: 2006 Impact factor: 13.739

Review 4. Genetic factors in the predisposition to drug-induced hypersensitivity reactions.

Authors: Munir Pirmohamed
Journal: AAPS J Date: 2006-02-03 Impact factor: 4.009

5. Intermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening?

Authors: B Laika; S Leucht; S Heres; W Steimer
Journal: Pharmacogenomics J Date: 2009-05-19 Impact factor: 3.550

6. CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.

Authors: Y Caraco; S Blotnick; M Muszkat
Journal: Clin Pharmacol Ther Date: 2007-09-12 Impact factor: 6.875

Review 7. Targeting the human epidermal growth factor receptor 2 (HER2) in the treatment of breast cancer: recent advances and future directions.

Authors: Rita Nanda
Journal: Rev Recent Clin Trials Date: 2007-05

Review 8. Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders.

Authors: Alessandro Serretti; Alberto Chiesa; Raffaella Calati; Giampaolo Perna; Laura Bellodi; Diana De Ronchi
Journal: Int Clin Psychopharmacol Date: 2009-01 Impact factor: 1.659

9. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.

Authors: P Michael Ho; Thomas M Maddox; Li Wang; Stephan D Fihn; Robert L Jesse; Eric D Peterson; John S Rumsfeld
Journal: JAMA Date: 2009-03-04 Impact factor: 56.272

10. Large scale association analysis of novel genetic loci for coronary artery disease.

Authors: N J Samani; P Deloukas; J Erdmann; C Hengstenberg; K Kuulasmaa; R McGinnis; H Schunkert; N Soranzo; J Thompson; L Tiret; A Ziegler
Journal: Arterioscler Thromb Vasc Biol Date: 2009-01-22 Impact factor: 8.311

4 in total

1. Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study.

Authors: Dong Ho Lee; Se Hyung Kim; Seock-Ah Im; Do-Youn Oh; Tae-Yong Kim; Joon Koo Han
Journal: Eur Radiol Date: 2015-11-28 Impact factor: 5.315